US Patent Issued to Incyte, Incyte Holdings on Feb. 10 for "Topical formulation for JAK inhibitor" (Pennsylvania, Texas Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,381, issued on Feb. 10, was assigned to Incyte Corp. (Wilmington, Del.) and Incyte Holdings Corp. (Wilmington, Del.).

"Topical formulation for JAK inhibitor" was invented by Bhavnish Parikh (Avondale, Pa.), Bhavesh Shah (San Antonio) and Krishnaswamy Yeleswaram (Landenberg, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders."

The patent was filed on April 5, 2025, under Applicatio...